compounding semaglutide enforcement news On February 21, 2025, the FDA announced that semaglutide, the active ingredient in Ozempic and Wegovy, is no longer considered in shortage, signaling an improvement in national supply. As a result, Semaglutide injections will no longer

When using Proov PdG tests to assess ovulation health, we like to see 3-4 positive test results on days 7-10 past peak fertility (i.e

But what we are pretty much sure of now, which has been clarified over the past two decades or so, is there's a very very strong biological basis for developing obesity

Tirzepatide may actually reduce UTI risk in diabetic patients by improving blood sugar control

The cons of a Noom diet plan include lack of structured guidance for sustainable lifestyle changes, a skewed focus on calorie range rather than wellness, and a high monthly cost

Take control of your healthcontact us now

At the other end of the spectrum, there is a smaller group cycling through cash-pay clinics, apps, and programs where DEXA is marketed as a precision truth-teller